india top 60 toc

Upload: anand-chaudhary

Post on 05-Apr-2018

226 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/2/2019 India Top 60 ToC

    1/10

  • 8/2/2019 India Top 60 ToC

    2/10

    Directory of

    Top 60 BiopharmaceuticalManufacturers in IndiaA mphnsv ndus vw: Pls sablshd,and apdl gwng, ganzans nvlvd n

    bmanuaung.

    September 2008

    BioPlan Associates, Inc.2275 rsah Blvd, Su 500rkvll, MD 20850 USA301.921.9074www.bplanassas.m

    cpgh 2008 b BPlan Assas, in.

    All ghs svd. Unauhzdpdun sl phbd.

  • 8/2/2019 India Top 60 ToC

    3/10

    Directory ofTop 60 Biopharmaceutical Manufacturers in IndiaA mphnsv ndus vw: Pls sablshd, andapdl gwng, ganzans nvlvd n bmanuaung.

    September 2008

    BioPlan Associates, Inc.2275 rsah Blvd, Su 500rkvll, MD 20850 USA301.921.9074www.bplanassas.m

    cpgh 2008 b BPlan Assas, in.

    All ghs svd, nludng h gh pdun n whl n pa n an

    m. N pa hs publan ma b pdud, sd n a val ssm,

    ansmd n an m b an mans, ln, mhanal, phpng,

    dng hws, whu h wn pmssn h publsh.

    f nman n spal dsuns pmssns na

    BPlan Assas, in. a 301-921-9074, [email protected]

    eds: Abhj c Klka, Dnl e. Sanl, and e S. Lang

    tx dsgn and Lau: eS illusan & Dsgn in., Alngn, VA

    cv Dsgn: t Agns

    iSBN 978-1-934106-12-9

  • 8/2/2019 India Top 60 ToC

    4/10

    www.bioplanassociates.com ii

    Prefaceths d s an n-gng pj pvd n-dph nman and nsghs

    n h apdl gwng and hangng indan bphamaual ndus. t

    h bs u knwldg, hs s h s d s knd. As h indan

    bphamaual ndus nnus xpand, h nman n hs d

    wll, nssal, bm udad.

    As suh, w wll hav n-sa sahs kp up--da. Hwv,

    u ads npu wll b nvaluabl n ha gad. i u hav mmns

    ns, plas wad hm us.

    th ankng mpans s basd n nman publl avalabl. fnanal

    smas n sm ass a basd n as suh as h numb mpls,

    al sz, and avalabl panshp sus.

    Baus h indan bphamaual ndus s n a gwh phas, sm h

    ganzans pld a mgng as ndus papans. ths mpans a

    nludd baus, basd n h human sus, h nnal xps, h

    nanal apabls, h ma hav h pnal apdl n hs mak whh wn blgal pdus.

    W wsh aknwldg h nbuns man ndvduals n inda, and

    aund h wld, wh hav vwd and valuad h nn hs d.

    Whu h supp, hs pj wuld n hav bn pssbl.

    in paula, w wsh hank Abhj c Klka, D2L Phama, (Bangal). M

    Klka was nsumnal n gahng h nman and nsung h aua and

    nn hs d.

    e S. Lang

    Managng Pan

    BPlan Assas, in.

    Spmb 2008

  • 8/2/2019 India Top 60 ToC

    5/10

    Photos Courtesy of Intas Pharmaceuticals.

  • 8/2/2019 India Top 60 ToC

    6/10

    www.bioplanassociates.com

    Table of Contents:

    1. Indian Biopharmaceutical Companies: The Developmentof Modern Biotechs in India ................................................1

    2. Study Methodology .............................................................7

    3. Summary of Indian Biopharmaceutical Manufacturers .......9

    4. Table 1: Top 60 Top 60 biopharmaceutical companiesin India (By Ranking) .........................................................11

    5. Table 2: Top 60 Biopharmaceutical Companiesin India (by Primary Business) ...........................................13

    6. Table 3: Additional Biopharmaceutical Companiesin India ..............................................................................16

    7. Proles of Indian Biopharmaceutical Organizations .........17

  • 8/2/2019 India Top 60 ToC

    7/10

    Photos Courtesy of Intas Pharmaceuticals.

  • 8/2/2019 India Top 60 ToC

    8/10

    www.bioplanassociates.com

    Indian Biopharmaceutical

    Companies: The Development ofModern Biotechs in India

    Overview: Indian Biopharmaceutical Industry

    Indas ns n h Bphamaual/Bh mak das bak 1925 whn Haffkine

    Institute (Plague Research Laboratory) bgan pdun vans n Mumba. in 1953,

    Unichem nd pdun and bgan xpng hmnal pdus. A ha m, indawas pmal dpndn n gn mpans m h uns gwng dmand

    bas mdan du s apdl gwng ppulan and qun pdms.

    La n h 1960s, man mpans w sablshd pdun vans. Sm

    pmnn ns nludd h Serum Institute of India, Biological E, Bharat Serums and

    Vaccines, VHB Life Sciences and Chandra Bhagat Pharma Pvt. Ltd. Smulanusl, h us

    als shd wads h nzm mak, and mpans suh as Biocon andAdvanced

    Enzymes nd n nzm pdun. Biocon, sablshd n 1978, bam h s

    indan mpan manuau and xp nzms h U.S. and eup.

    inda has mvd m mpl dpndn n gn mulnanals bmng a maj

    suppl vans h glbal mak, whh mans a maj sgmn h indan

    bphama mak. th indan lal van mak s unl n h gn USD$100

    mlln and s gwng a h a m han 20% p annum.

    inda s h lags pdu rmbnan Hpas B van n h wld da. Serum

    Institute, whh sad n h al 1960s, ps sl da b h snd lags

    manuau vans, and lams ha 1 v 2 kds n h wld s vanad b

    Sums van.

    Ms h maj indan mpans nvlvd n bphamauals a lagl nnd h aas adnal bhnlg lk mnan and vans. th dms

    indan bphama sgmn nvlvd n mbnan DNA pdun s sll vlvng. Unl

    h 1990s, h indan mbnan pdu mak was mpll dmnad b glbal

    majs suh as Novo Nordiskand Eli Lilly & Co. indas n n mbnan pdus

    sad wh h launh HU-ehpn (Hmax) n h indan mak n 1993

    b Hindustan Antibiotics, llwd b h Hpas B van m Shantha Biotech, and

    a a la b Bharat Biotech, anh Hdabad-basd mpan, whh als nd h

    hpas van mak.

    A uh bakhugh n mbnan pdus was wh h launh mbnanHpas-B van (Bva-B) b Wockhardtand (GnVa-B) b Serum Institute n 2000

    and 2001, spvl. Wockhardtals launhd s rmbnan hpn (Wpx)

    n 2001, and -DNA human nsuln (Wsuln) n 2003, Asas s mbnan nsuln.

    th indan bphama s bam h lags s bh ndus n inda wh

    a gwh a 31.8% n 2006 and aund a 72.2% sha wh vnus USD

    $1.05 blln.

    1

  • 8/2/2019 India Top 60 ToC

    9/10

    2008 BioPlan associates, inc. UnaUthorized reProdUction strictly ProhiBited. all rights reserved.

    top 60 biopharmaceutical manufacturers in india

    A maj h indan bh nduss nbuns m m s bphamaual

    sgmn, bu als nluds h sgmns suh as bagulu, bnma,

    bsvs, and bndus. th maj xps n h bh s a mad bbphama mpans. tda, inda anks 11h n h wld and 3d n h Asa-Pa n

    ms mpan un wh v 300 bhnlg-lad ms.

    Current Trends in Biopharma India Changing theParadigm

    A psn, h bphamaual ndus n inda s manl mpsd h

    sgmns: mbnan dugs, mnlnal anbds (mAbs), and vans. Muh

    h ndus uss n manuaung bh dugs hugh h mnan pss.Ms h al mpans w n h van busnss, whh ld mak sauan

    and nasd mpn n h dms mak; nw wh pvn qual and s

    vnss, hs sam mpans a lkng ap h glbal maks a bad

    aa blgs. th us s nw n banng a sha h unddvlpd mak,

    as wll as supplng h Wld Halh oganzan (WHo), UNicef, and h nn-

    gvnmn ganzans. th ndus s als sng s sghs n h hapu nds

    dvlpd uns n Nh Ama and eup.

    inda s h snd lags manuau vans usd b hldn, wh Serum Institute

    as a maj nbu n h wld van mak. in 1999, Serum Institute was gnzdas h lags pdu Masls and DtP vans n h wld.

    rgnzng h pnal indan mpans, sval gn mpans a wkng wh

    dms indan manuaus nlusn n h indan mak. f xampl,Acambis

    Plc., a UK-basd van dvlp, has a manuaung and makng agmn wh

    Bharat Biotech s nvsganal van agans Japans enphals.

    fusng n dvlpmn m mplx mbnan vans, h llwng dms

    mpans hav dvlpd vans a va uss:

    Panacea Biotech pand wh Chiron Vaccines (US) dvlp a ull lqud

    pnavaln mbnan van v nus dsass: dphha, anus,

    whpng ugh, Hpas-B and H.inunza p b;

    Shantha Biotechnics launhd s u-n-n van, Shana, agans u l-

    hanng nns nludng dphha, anus, pusss and hpas B; and

    Serum Institute s manuaung an ndgnus DtP and Hpas B mbnan

    van, Q-Va.

    inda s wkng wad sl-sun and ga ndpndn m gn mpans

    pdu nnvans hnlg. i nw xps vans m han 100 uns

    aund h wld. Sm indan mpans a xpnng sgnan gwh, suh as

    Biocon. i has dvlpd xps n sld sa mnan, whh s 4 20 ms m

    v han n-lqud sa mnan. Biocon s h nl mpan n h wld, whh

    has h hnlg mak dugs usng gnall ngnd mgansms n a sld-

    sa mn.

    ...This directory includes417 pages of information,

    data and companyintelligence...

  • 8/2/2019 India Top 60 ToC

    10/10